NO172797C - Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolforbindelser

Info

Publication number
NO172797C
NO172797C NO901451A NO901451A NO172797C NO 172797 C NO172797 C NO 172797C NO 901451 A NO901451 A NO 901451A NO 901451 A NO901451 A NO 901451A NO 172797 C NO172797 C NO 172797C
Authority
NO
Norway
Prior art keywords
bond
preparation
chem
imidazole compounds
together form
Prior art date
Application number
NO901451A
Other languages
English (en)
Norwegian (no)
Other versions
NO901451L (no
NO172797B (no
NO901451D0 (no
Inventor
Arto Johannes Karjalainen
Reino Olavi Pelkonen
Marja-Liisa Soedervall
Matti Antero Laehde
Risto Arvo Sakari Lammintausta
Arja Leena Karjalainen
Arja Marketta Kalapudas
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB8907218A external-priority patent/GB2229719B/en
Priority claimed from GB8907309A external-priority patent/GB2231568B/en
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of NO901451D0 publication Critical patent/NO901451D0/no
Publication of NO901451L publication Critical patent/NO901451L/no
Priority to NO911040A priority Critical patent/NO172119C/no
Publication of NO172797B publication Critical patent/NO172797B/no
Publication of NO172797C publication Critical patent/NO172797C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Epoxy Resins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Ceramic Products (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO901451A 1989-03-30 1990-03-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolforbindelser NO172797C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO911040A NO172119C (no) 1989-03-30 1991-03-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazol-forbindelser

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8907218A GB2229719B (en) 1989-03-30 1989-03-30 Novel aromatase inhibiting 4(5)-imidazoles
GB8907309A GB2231568B (en) 1989-03-31 1989-03-31 New aromatase inhibiting 4(5)-imidazoles

Publications (4)

Publication Number Publication Date
NO901451D0 NO901451D0 (no) 1990-03-29
NO901451L NO901451L (no) 1990-10-01
NO172797B NO172797B (no) 1993-06-01
NO172797C true NO172797C (no) 1993-09-08

Family

ID=26295152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901451A NO172797C (no) 1989-03-30 1990-03-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolforbindelser

Country Status (19)

Country Link
EP (1) EP0390558B1 (cs)
JP (1) JPH032168A (cs)
CN (2) CN1046527A (cs)
AT (1) ATE111084T1 (cs)
AU (1) AU627559B2 (cs)
CZ (1) CZ281611B6 (cs)
DE (1) DE69012184T2 (cs)
DK (1) DK0390558T3 (cs)
ES (1) ES2063260T3 (cs)
HU (2) HU205345B (cs)
IE (1) IE64655B1 (cs)
IL (1) IL93940A (cs)
LV (1) LV11027B (cs)
NO (1) NO172797C (cs)
NZ (1) NZ233127A (cs)
PL (1) PL162513B1 (cs)
PT (1) PT93606B (cs)
RU (1) RU1836354C (cs)
UA (1) UA13471A (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB2229719B (en) 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
GB2248058B (en) * 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
US7902247B2 (en) * 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2110663B (en) * 1981-12-04 1985-08-07 Farmos Group Ltd Imidazole derivatives
LU85747A1 (fr) * 1985-01-28 1986-08-04 Continental Pharma Derives d'imidazole leur preparation et utilisation ainsi que les compositions pharmaceutiques contenant des derives
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles

Also Published As

Publication number Publication date
NO901451L (no) 1990-10-01
CZ155590A3 (en) 1996-08-14
JPH032168A (ja) 1991-01-08
HU914010D0 (en) 1992-03-30
NZ233127A (en) 1991-03-26
CN1086812A (zh) 1994-05-18
RU1836354C (ru) 1993-08-23
HUT53357A (en) 1990-10-28
PT93606B (pt) 1996-08-30
LV11027B (en) 1996-08-20
UA13471A (uk) 1997-02-28
PL162513B1 (pl) 1993-12-31
IE64655B1 (en) 1995-08-23
NO172797B (no) 1993-06-01
CZ281611B6 (cs) 1996-11-13
DE69012184T2 (de) 1995-01-05
ATE111084T1 (de) 1994-09-15
AU627559B2 (en) 1992-08-27
LV11027A (lv) 1996-02-20
AU5232590A (en) 1990-10-04
HU205345B (en) 1992-04-28
EP0390558A1 (en) 1990-10-03
CN1046527A (zh) 1990-10-31
IL93940A0 (en) 1990-12-23
IE901152L (en) 1990-09-30
PL284552A1 (en) 1991-07-29
PT93606A (pt) 1990-11-20
ES2063260T3 (es) 1995-01-01
HU206685B (en) 1992-12-28
NO901451D0 (no) 1990-03-29
DE69012184D1 (de) 1994-10-13
EP0390558B1 (en) 1994-09-07
DK0390558T3 (da) 1994-10-10
HU901894D0 (en) 1990-08-28
IL93940A (en) 1994-10-07

Similar Documents

Publication Publication Date Title
MA23639A1 (fr) Derives pyrrocarbazole, leur preparation, les compositions pharmaceutiques les contenant, leur utilisation dans le traitement des tumeurs malignes.
NO172797C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolforbindelser
NO902861L (no) Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
HUT50354A (en) Process for producing new s-adenosylmethionine decarboxilase inhibitors
NO913712L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
ES8407464A1 (es) Un procedimiento para la preparacion de derivados de etanolamina.
KR890000406A (ko) 신나모일아미드 유도체, 그들의 제조방법, 그들을 함유하는 제약학적 조성물 및 그들의 사용
HUT47938A (en) Process for producing indoloquinoxaline derivatives with substituent in 6-position containing cyclic group, as well as pharmaceuticals comprising these compounds as active ingredient
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ES8305377A1 (es) Un procedimiento para la preparacion de un derivado de nitrosourea.
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE63544T1 (de) 4-cyanopiperidine-derivate, herstellung und anwendung.
GB1005876A (en) Benzenesulphonyl-urea derivatives and a process for their manufacture